Articles

Do We Need a Different Approach to Assess Cardiovascular Risk in Women?

Ijeoma Isiadinso, Nanette K Wenger

US Cardiology Review 2017;11(1):5–9

DOI: https://doi.org/10.15420/usc.2016:8:2
Cardiac Toxicity of Cancer Chemotherapy

Aarti Asnani, Randall T Peterson

US Cardiology Review 2017;11(1):20–4

DOI: https://doi.org/10.15420/usc.2017:2:2
Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy

Donald E Cutlip

US Cardiology Review 2017;11(1):31–6

DOI: https://doi.org/10.15420/usc.2017:7:2
When to Use Bioresorbable Vascular Scaffolds

Xiaoyu Yang, Mohamed Ahmed, Donald E Cutlip

US Cardiology Review 2017;11(1):25–30

DOI: https://doi.org/10.15420/usc.2017:3:2
Practical Aspects of Rotor Mapping in Catheter Ablation of Atrial Fibrillation

John M Miller

US Cardiology Review 2017;11(1):39–41

DOI: https://doi.org/10.15420/usc.2017:4:2
Guest Editorial: A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin?

Michela Faggioni, Michael C Gibson, Roxana Mehran

US Cardiology Review 2017; 11(1):37–8

DOI: https://doi.org/10.15420/usc.2017:6:1.GE
Guest Editorial: Commentary on the Findings of the GLAGOV Randomized Clinical Trial

Jakub Podolec, Lukasz Niewiara

US Cardiology Review 2017;11(1):18–9

DOI: https://doi.org/10.15420/usc.11.1.GE
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease

Shane Prejean, Todd M Brown

US Cardiology Review 2017;11(1):16–7

DOI: https://doi.org/10.15420/usc.2017:5:2
Dyslipidemia: Current Therapies and Guidelines for Treatment

Edward T Carreras, Donna M Polk

US Cardiology Review 2017;11(1):10–5

DOI: https://doi.org/10.15420/usc.2016:9:2
Current Status of the Left Ventricular Assist Device as a Destination Therapy

Jorge Silva Enciso, Eric Adler, Barry H Greenberg

US Cardiology Review 2016;10(2):85–90

DOI: http://dx.doi.org/10.15420/usc.2016:6:2
Pharmacologic Strategies for Management of Pulmonary Arterial Hypertension

Rebecca L Attridge, Rebecca D Moote, Deborah J Levine

US Cardiology Review, 2016;10(2):78–84

DOI: http://dx.doi.org/10.15420/usc.2016:2:2
Subclinical Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy

Braghadheeswar Thyagarajan, Ankur Kalra, Alefiyah Rajabali, Jill B Whelan, Elad Anter

US Cardiology Review 2016;10(2):75-7

DOI: http://dx.doi.org/10.15420/usc.2016:7:2
Bridging the Knowledge Gaps in Arrhythmogenic Cardiovascular Conditions: The Critical Role of Registries

Melody Hermel, Rebecca Duffy, Alexander Orfanos, Isabelle Hack, Shayna McEnteggart, Kayle Shapero, Supria Batra, NA Mark Estes III

US Cardiology Review, 2016;10(2):65–74

DOI: http://dx.doi.org/10.15420/usc.2016:3:2
ST-segment Elevation Myocardial Infarction: Challenges in Diagnosis

Robert F Riley, James M McCabe

US Cardiology Review, 2016;10(2):91–4

DOI: http://dx.doi.org/10.15420/usc.2016:5:2
What the Cardiologist Needs to Know About Medications for Type 2 Diabetes

Stephen Ku, Steven V Edelman

US Cardiology Review, 2016;10(2):54–9

DOI: http://dox.doi.org/10.15420/usc. 2016:4:2

Pages